ChromaDex (CDXC)
(Real Time Quote from BATS)
$3.19 USD
+0.17 (5.63%)
Updated Aug 15, 2024 11:42 AM ET
1-Strong Buy of 5 1
D Value A Growth C Momentum B VGM
Brokerage Reports
ChromaDex Corporation [CDXC]
Reports for Purchase
Showing records 61 - 80 ( 120 total )
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Top- and Bottom-Line Beat; 2Q20 Financials; Raising PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Potential NIAGEN Applicability in Autism; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
New Coronavirus Cell Model Data Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
1Q20 Financials; Top- and Bottom-Line Beat; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
COVID-19 Research Promise; Beauty Product Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Legal Situation Update; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
2019 Financials Reported; Profitability Still a Distance Away; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
New Clinical Results Indicate Possible Additional NIAGEN Utility; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
European and Australian Regulatory Milestones Achieved; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Asian Market Turmoil Impeding Growth; Long-Term Attractiveness; Reiterate Buy; Modulating Target to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
1Q19 Financial Results Reported; Cash Replenished; E-Commerce Sales Accelerating; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
TRU NIAGEN Canada Distribution Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Revising Revenue and Spending Projections; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
2018 Financial Results Reported; Revenue and Earnings Largely In-Line; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Fresh From Patent Validation Victory, ChromaDex Goes on the Attack; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Partnership Inked With Nestle Health Sciences; Raising Target to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Top-Line and Bottom-Line Miss for 3Q18; Reducing Price Target to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
TRU NIAGEN PRO Launched in Partnership With Natural Partners Fullscript; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Chinese Province Strategic Partnership; Patent Infringement Complaint Filed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R